Correction: Postoperative Chemoradiotherapy versus Postoperative Chemotherapy for Completely Resected Gastric Cancer with D2 Lymphadenectomy: A Meta-Analysis.

Correction: Postoperative Chemoradiotherapy versus Postoperative Chemotherapy for Completely Resected Gastric Cancer with D2 Lymphadenectomy: A Meta-Analysis.

Show other versions (1)

Bibliographic Details
Main Authors:	Yuan-Yuan Huang, Qiong Yang, Si-Wei Zhou, Ying Wei, Yan-Xian Chen, De-Rong Xie, Bei Zhang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3731372

Similar Items

Postoperative chemoradiotherapy versus postoperative chemotherapy for completely resected gastric cancer with D2 Lymphadenectomy: a meta-analysis.
by: Yuan-Yuan Huang, et al.
Published: (2013-01-01)

Correction: Postoperative Chemoradiotherapy versus Postoperative Chemotherapy for Completely Resected Gastric Cancer with D2 Lymphadenectomy: A Meta-Analysis
by: Yuan-Yuan Huang, et al.
Published: (2013-01-01)

Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy
by: Qiong Yang, et al.
Published: (2013-01-01)

Preoperative Chemoradiotherapy Versus Postoperative Chemoradiotherapy for Patients With Locally Advanced Gastric Cancer: A Retrospective Study Based on Propensity Score Analyses
by: Wang Yang, et al.
Published: (2020-10-01)

Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
by: Ran Duan, et al.
Published: (2021-01-01)

Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
by: Qifeng Wang, et al.
Published: (2020-05-01)

Comparison of Perioperative Chemotherapy versus Postoperative Chemoradiotherapy for Operable Stomach Cancer: A Western Canadian Province Experience
by: Adnan Zaidi, et al.
Published: (2021-03-01)

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer
by: Hsueh-Ju Lu, et al.
Published: (2015-01-01)

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
by: van Grieken Nicole CT, et al.
Published: (2011-08-01)

Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis
by: Liyu Su, et al.
Published: (2019-10-01)

The effect of fibrin glue on the postoperative lymphatic leakage after D2-lymphadenectomy and gastrectomy in patients with gastric cancer
by: Habibollah Mahmoodzadeh, et al.
Published: (2021-03-01)

The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy
by: Qiao-xuan Wang, et al.
Published: (2021-01-01)

The Postoperative Component of MAGIC Chemotherapy Is Associated with Improved Prognosis following Surgical Resection in Gastric and Gastrooesophageal Junction Adenocarcinomas
by: A. Mirza, et al.
Published: (2013-01-01)

Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer
by: Jun Lu, et al.
Published: (2019-09-01)

The efficiency of D1(+) lymphadenectomy in signet ring cell carcinoma: comparison of postoperative early and late outcomes between standard lymphadenectomy and D1(+) lymphadenectomy
by: Şevket Barış Morkavuk, et al.
Published: (2021-01-01)

Association Between the Microsatellite Instability Status and the Efficacy of Postoperative Adjuvant Chemoradiotherapy in Patients With Gastric Cancer
by: Dongfang Dai, et al.
Published: (2020-01-01)

Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction.
by: Guichao Li, et al.
Published: (2013-01-01)

Mediastinal lymphadenectomy influences postoperative immune response after lung cancer surgery
by: Tomasz SZCZESNY, et al.
Published: (2008-10-01)

Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy
by: Vidal Oscar, et al.
Published: (2006-08-01)

Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer
by: Keying Che, et al.
Published: (2020-10-01)

Postoperative Chemotherapy for Medulloblastoma
by: J Gordon Millichap
Published: (2005-03-01)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
by: Astrid E. Slagter, et al.
Published: (2018-09-01)

Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy
by: Jing Xu, et al.
Published: (2020-07-01)

Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer
by: Qing Tao, et al.
Published: (2020-04-01)

Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages
by: Guanzhang Li, et al.
Published: (2020-03-01)

Impact of postoperative major complications on long-term survival after radical resection of gastric cancer
by: Peng Yuan, et al.
Published: (2019-08-01)

Postoperative Concurrent Chemoradiotherapy versus Postoperative Radiotherapy Alone for Larynx Squamous Cell Carcinoma Patients with Lymphovascular Invasion: A Propensity Score Matching Study
by: Yu S, et al.
Published: (2020-05-01)

A Case of Noncuratively Resected Gastric Cancer and Postoperative Chemotherapy with S-1 Monotherapy Resulting in Long-Term Survival for Over 8 Years
by: Byoung Jo Suh
Published: (2017-02-01)

Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis.
by: Changhoon Song, et al.
Published: (2015-01-01)

The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma
by: Ming-Wei Ma, et al.
Published: (2018-08-01)

Impact of Resected Gastric Volume on Postoperative Weight Loss after Laparoscopic Sleeve Gastrectomy
by: Stefano D’Ugo, et al.
Published: (2019-01-01)

Early postoperative imaging after non-bariatric gastric resection: a primer for radiologists
by: Massimo Tonolini, et al.
Published: (2017-06-01)

Comprehensive Complication Index Predicts Cancer-Specific Survival of Patients with Postoperative Complications after Curative Resection of Gastric Cancer
by: Ru-Hong Tu, et al.
Published: (2018-01-01)

Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies
by: Ma JT, et al.
Published: (2016-07-01)

Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study
by: Sanghyuk Song, et al.
Published: (2017-08-01)

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques
by: Tae Hyung Kim, et al.
Published: (2021-03-01)

Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis
by: Yuqiao Chen, et al.
Published: (2018-01-01)

Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study
by: Masahiro Kagabu, et al.
Published: (2021-05-01)

Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis
by: Daniel M. Girardi, et al.
Published: (2018-04-01)

Efficacy of Postoperative FOLFOX Versus XELOX Chemotherapy for Gastric Cancer and Prognostic Value of Platelet–Lymphocyte Ratio in Patients Receiving XELOX
by: Xin Yin, et al.
Published: (2020-12-01)

Cannot write session to /tmp/vufind_sessions/sess_qst7fq1dfqur34m3d1viks479v